Bank of New Hampshire’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.1K Sell
432
-279
-39% -$18.6K 0.01% 375
2026
Q1
$44.7K Sell
711
-260
-27% -$18.1K 0.01% 324
2025
Q4
$64.4K Sell
971
-10,228
-91% -$661K 0.01% 272
2025
Q3
$754K Sell
11,199
-90
-0.8% -$7.12K 0.17% 107
2025
Q2
$985K Sell
11,289
-300
-3% -$23.5K 0.25% 92
2025
Q1
$791K Sell
11,589
-124
-1% -$10.1K 0.21% 103
2024
Q4
$911K Sell
11,713
-748
-6% -$55.4K 0.23% 90
2024
Q3
$835K Buy
12,461
+808
+7% +$66.4K 0.21% 100
2024
Q2
$1.32M Buy
11,653
+781
+7% +$98.7K 0.34% 79
2024
Q1
$1.51M Buy
+10,872
New +$1.37M 0.4% 75
2022
Q2
Sell
-148
Closed -$19K 525
2022
Q1
$19K Buy
+148
New +$16.2K ﹤0.01% 426

Other funds holding DXCM

Bank of New Hampshire's DXCM Position: Q2 2026 in Review

Bank of New Hampshire reduced its DexCom (DXCM) stake by 39% in Q2 2026, selling an estimated $18.6K and leaving 432 shares worth $29.1K. The position accounts for 0.01% of the portfolio, ranked #375.

Bank of New Hampshire first reported a position in DXCM in Q1 2022 and has held it in 11 quarters since. The position peaked at $1.51M in Q1 2024. 496 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Bank of New Hampshire held 432 shares of DexCom worth $29.1K as of Q2 2026.
  • Bank of New Hampshire sold 279 DexCom shares in Q2 2026, an estimated $18.6K.
  • DexCom made up 0.01% of Bank of New Hampshire's portfolio in Q2 2026, its #375 holding.
  • Bank of New Hampshire first reported a position in DexCom in Q1 2022 and has held it in 11 quarters since.
  • Bank of New Hampshire's DexCom position peaked at $1.51M in Q1 2024.
  • 496 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.